IPD
ImpediMed Ltd
Healthcare Equipment and Supplies
·
Healthcare
4
comments
3
fund managers
past 90 days
About ImpediMed Ltd
ImpediMed Ltd. develops and distributes medical bioimpedance spectroscopy devices for fluid status management. Its flagship product, SOZO, provides critical body composition data to assist clinicians in managing chronic diseases and improving patient outcomes. Founded in 1999 by Melvyn and Lucille Bridges, the company is headquartered in Pinkenba, Australia. ImpediMed focuses on leveraging advanced bioimpedance technology to support clinical decision-making and enhance healthcare delivery.
Commentary Volume
4
Comments
3
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$1M
Fund managers
3 managers
First covered
31 Oct 2023
Last updated
30 Nov 2024
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about ImpediMed Ltd (ASX:IPD)
Frequently asked questions
Who is investing in ImpediMed Ltd (ASX:IPD)?
Fund managers including Monash Investors, QVG Capital and Lakehouse Capital have invested in ImpediMed Ltd (ASX:IPD).
What is the short interest in ImpediMed Ltd (ASX:IPD)?
The short interest in ImpediMed Ltd (ASX:IPD) is 0.62% which makes it the 262nd most shorted stock on the ASX. Of the 2.0B shares that ImpediMed Ltd has on issue, 12.7M have been sold short.
What does ImpediMed Ltd (ASX:IPD) do?
ImpediMed Ltd. develops and distributes medical bioimpedance spectroscopy devices for fluid status management. Its flagship product, SOZO, provides critical body composition data to assist clinicians in managing chronic diseases and improving patient outcomes. Founded in 1999 by Melvyn and Lucille Bridges, the company is headquartered in Pinkenba, Australia. ImpediMed focuses on leveraging advanced bioimpedance technology to support clinical decision-making and enhance healthcare delivery.
Loading...